UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

Annals of oncology, 2004-07, Vol.15 (7), p.1042-1047

2004

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66]

Annals of oncology, 2022-04, Vol.33 (4), p.454-454

2022

Link zum Volltext

Verfügbarkeit prüfen

Eruptive cherry angiomas and uveal melanoma: beyond a simple association

Clinical and experimental dermatology, 2021-07, Vol.46 (5), p.946-948

2021

Link zum Volltext

Verfügbarkeit prüfen

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

Clinical pharmacology and therapeutics, 2012-06, Vol.91 (6), p.1022-1026

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

British journal of cancer, 2009-07, Vol.101 (2), p.219-224

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial

Annals of oncology, 2018-10, Vol.29, p.viii506-viii507

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Clinical & translational oncology, 2020-03, Vol.22 (3), p.294-301

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of ceritinib administered to patients with crizotinib-refractory, ALK-positive, advanced NSCLC within the Italian compassionate use program

Annals of oncology, 2017-10, Vol.28, p.vi56-vi57

2017

Link zum Volltext

Verfügbarkeit prüfen

3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

European journal of cancer (1990), 2015-09, Vol.51, p.S634-S634

2015

Link zum Volltext

Verfügbarkeit prüfen

Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib

Clinical pharmacology and therapeutics, 2008-03, Vol.83 (3), p.477-484

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)

British journal of cancer, 2004-01, Vol.90 (1), p.82-86

2004

Link zum Volltext

Verfügbarkeit prüfen

EP14.01-05 Neo-Adjuvant Immunotherapy in Malignant Pleural Mesothelioma: Report on Three Cases Treated in a Single Institution

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S713-S714

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience

Journal of cardiovascular surgery, 2011-08, Vol.52 (4), p.613

2011

Link zum Volltext

Verfügbarkeit prüfen

863P Microbiota and cytokines profile in patients (pts) affected by recurrent metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs) +/- chemotherapy (CT) and prebiotic inulin in the PRINCESS study

Annals of oncology, 2023-10, Vol.34, p.S560-S560

2023

Link zum Volltext

Verfügbarkeit prüfen

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2004-08, Vol.96 (15), p.1133-1141

2004

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer

The quarterly journal of nuclear medicine and molecular imaging, 2005-09, Vol.49 (3), p.259

2005

Link zum Volltext

Verfügbarkeit prüfen

1610P Delivery of ONCOlogic care at HOME: Ready for “ONCOHOME”

Annals of oncology, 2021-09, Vol.32, p.S1149-S1149

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapeutic Advances for NSCLC

Biologics, 2021-01, Vol.15, p.399-417

2021

Link zum Volltext

Verfügbarkeit prüfen

A0340 - Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?

European urology, 2023-02, Vol.83, p.S495-S496

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?

European urology, 2023-02, Vol.83, p.S495-S496

2023

Link zum Volltext

Verfügbarkeit prüfen

1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

Annals of oncology, 2020-09, Vol.31, p.S805-S806

2020

Link zum Volltext

Verfügbarkeit prüfen

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-12, Vol.42 (3), p.275-281

2003

Link zum Volltext

Verfügbarkeit prüfen

1588TiP - The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30, p.v656-v656

2019

Link zum Volltext

Verfügbarkeit prüfen

The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer

Annals of oncology, 2019-10, Vol.30, p.v656

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(14)
Biological And Medical Sciences
(11)
Female
(11)
Male
(11)
Oncology
(11)
Aged
(10)
Medical Sciences
(9)
Middle Aged
(9)
Adult
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)
Lung Neoplasms - Drug Therapy
(7)
Lung Neoplasms - Pathology
(7)
Antineoplastic Agents - Therapeutic Use
(5)
Apis Mellifera
(5)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Chemotherapy
(5)
Hematology, Oncology And Palliative Medicine
(5)
Immunohistochemistry
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

Eruptive cherry angiomas and uveal melanoma: beyond a simple association

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Efficacy of ceritinib administered to patients with crizotinib-refractory, ALK-positive, advanced NSCLC within the Italian compassionate use program

3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)

EP14.01-05 Neo-Adjuvant Immunotherapy in Malignant Pleural Mesothelioma: Report on Three Cases Treated in a Single Institution

Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience

863P Microbiota and cytokines profile in patients (pts) affected by recurrent metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs) +/- chemotherapy (CT) and prebiotic inulin in the PRINCESS study

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non–Small-Cell Lung Cancer

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer

1610P Delivery of ONCOlogic care at HOME: Ready for “ONCOHOME”

Immunotherapeutic Advances for NSCLC

A0340 - Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?

Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?

1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer

1588TiP - The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer

The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer

Suchergebnisse filtern